The Cerecyte product line includes the MicruSphere, Presidio, HeliPaq and UltiPaq Cerecyte embolic coils, for the endovascular treatment of cerebral aneurysms.
Sales of the company’s Cerecyte microcoils will be managed by Goodman, Micrus Endovascular’s exclusive distributor in the Japanese market.
John Kilcoyne, chairman and CEO of Micrus Endovascular, said: “The approval of our Cerecyte line of microcoils represents a major opportunity for Micrus. We can now provide the Japanese neurointerventionalists with a full line of both platinum and Cerecyte coils for the treatment of cerebral aneurysms.”